HALO
Halozyme Therapeutics Inc
$111.55
0.00 (0.00%) Today
1.04 (0.94%) Pre-market
— up— down
Market Cap
$12.66B+52.2%
Revenue (TTM)
$1.63B+41.1%
Net Income (TTM)
$396.96M-23.5%
EPS (TTM)
3.35-23.5%
Shares Out
118.61M
118.61MP/E Ratio
31.05
31.05Forward P/E
11.43
11.43Open
$111.56
$111.56Previous Close
$111.56
$111.56Day Range
$111.03 – $114.52
$111.03 – $114.5252-Week Range
$61.23 – $116.85
$61.23 – $116.85Beta
0.96
0.96Volume
2.57M
2.57MAvg Volume
2.04M
2.04MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout HALO
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Related
News
N/A
N/A
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Yahoo · 6d ago
$1000 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth This Much Today
Benzinga · 1w ago
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
Yahoo · 1w ago